Attention Deficit Hyperactivity Disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Meet the Western medical diagnosis of attention deficit hyperactivity disorder in children and Chinese medicine identification criteria; 2. Age 6-14 years old; 3. Not taking other attention deficit hyperactivity disorder-related Western and Chinese medication 2 weeks before entering the clinical study; 4. Not participating in other clinical trials; 5. Informed consent and able to accept the prescribed treatment regimen (e.g., duration of medication, frequency of visits,etc.).
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the inclusion criteria; 2. Those with a combination of serious organic diseases such as cardiovascular (especially those with structural abnormalities of cardiac function), hepatic, renal, hematopoietic, and neurological (epilepsy); 3. hyperactivity symptoms resulting from severe psychological and psychiatric disorders such as mental retardation, autism spectrum disorder, pervasive developmental disorder, childhood schizophrenia, mania, specific learning skills developmental disorder, etc; 4. Hearing or visual impairment; 5. allergy to the test drug; 6. those who participated in clinical trials of other drugs within the last 3 months; 7. Those who, in the judgment of the physician, are prone to lost visits; 8. Patients who have used monoamine oxidase inhibitors within the last 2 weeks; 9. Patients with severe gastrointestinal strictures (pathologic or medically induced), dysphagia, or significant difficulty swallowing pills; 10. Patients with glaucoma, patients with Tourette's syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SNAP-IV?Conners?Weiss;Chinese Medicine Evidence Scoring Scale; | — |
Countries
China
Contacts
Longhua Hospital